P Sharpstone

1.1k total citations
38 papers, 721 citations indexed

About

P Sharpstone is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P Sharpstone has authored 38 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P Sharpstone's work include Renal Diseases and Glomerulopathies (7 papers), Dialysis and Renal Disease Management (7 papers) and Erythropoietin and Anemia Treatment (4 papers). P Sharpstone is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Dialysis and Renal Disease Management (7 papers) and Erythropoietin and Anemia Treatment (4 papers). P Sharpstone collaborates with scholars based in United Kingdom, Australia and Romania. P Sharpstone's co-authors include C S Ogg, J S Cameron, Roger Williams, J. D. Parkes, J.C. Kingswood, David R. Turner, David Goldsmith, J. S. Cameron, Colin B. Brown and Chris Farmer and has published in prestigious journals such as The Lancet, Kidney International and Archives of Disease in Childhood.

In The Last Decade

P Sharpstone

37 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Sharpstone United Kingdom 14 256 112 112 106 88 38 721
R. Morrison Hurley United States 15 221 0.9× 108 1.0× 173 1.5× 65 0.6× 65 0.7× 46 728
Frank T. Maher United States 18 218 0.9× 239 2.1× 198 1.8× 90 0.8× 123 1.4× 37 897
Donald S. Fraley United States 18 393 1.5× 236 2.1× 288 2.6× 57 0.5× 110 1.3× 32 969
Yaacov Bar‐Khayim Israel 14 230 0.9× 93 0.8× 83 0.7× 81 0.8× 40 0.5× 41 593
H Bucht Sweden 19 442 1.7× 134 1.2× 163 1.5× 179 1.7× 57 0.6× 55 937
M Beaufils France 14 169 0.7× 76 0.7× 112 1.0× 290 2.7× 63 0.7× 58 1.1k
D Zevin Israel 13 156 0.6× 135 1.2× 129 1.2× 63 0.6× 56 0.6× 57 605
Lars‐Eric Lins Sweden 14 192 0.8× 123 1.1× 123 1.1× 146 1.4× 131 1.5× 33 712
J. Delanghe Belgium 10 117 0.5× 106 0.9× 58 0.5× 95 0.9× 72 0.8× 23 592
Watson C. Arnold United States 12 111 0.4× 95 0.8× 89 0.8× 45 0.4× 52 0.6× 35 450

Countries citing papers authored by P Sharpstone

Since Specialization
Citations

This map shows the geographic impact of P Sharpstone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Sharpstone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Sharpstone more than expected).

Fields of papers citing papers by P Sharpstone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Sharpstone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Sharpstone. The network helps show where P Sharpstone may publish in the future.

Co-authorship network of co-authors of P Sharpstone

This figure shows the co-authorship network connecting the top 25 collaborators of P Sharpstone. A scholar is included among the top collaborators of P Sharpstone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Sharpstone. P Sharpstone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donohoe, Paul, Nick Bishop, Timothy C. Doyle, et al.. (2015). A Four-Year Audit of Interventional Treatment for Atheromatous Renal Artery Stenosis. Contributions to nephrology. 119. 78–82.
2.
Farmer, Chris, et al.. (1998). Progression of diabetic nephropathy-is diurnal blood pressure rhythm as important as absolute blood pressure level?. Nephrology Dialysis Transplantation. 13(3). 635–639. 80 indexed citations
3.
Davies, Graham, Elizabeth Greenwood, J.C. Kingswood, P Sharpstone, & M. K. Street. (1996). Quinine Clearance in Continuous Venovenous Hemofiltration. Annals of Pharmacotherapy. 30(5). 487–490. 6 indexed citations
4.
Kingswood, J.C., et al.. (1996). Haemodynamic Changes Measured by Transthoracic Bioimpedance During Treatment with Recombinant Human Erythropoietin. Clinical and Experimental Hypertension. 18(1). 51–64. 2 indexed citations
5.
McGonigle, R J & P Sharpstone. (1980). Procedures in practice. Kidney biopsy.. BMJ. 280(6213). 547–549. 4 indexed citations
6.
Horn, Christopher B., et al.. (1980). Hemoperfusion in Acute Drug Toxicity. Clinical toxicology. 17(4). 547–556. 9 indexed citations
7.
Trafford, J. A. P., et al.. (1979). Screening for hypertension: a hospital-based home-vising programme.. BMJ. 2(6204). 1556–1556. 3 indexed citations
8.
McGonigle, R J, J. A. P. Trafford, P Sharpstone, & J.S. Tapson. (1979). Survival after bilateral renal artery occlusion.. BMJ. 2(6200). 1261–1267. 7 indexed citations
9.
Trafford, J. A. P., et al.. (1979). Evaluation of ultra-short dialysis.. BMJ. 1(6162). 518–519. 4 indexed citations
10.
Trafford, J. A. P., et al.. (1977). Haemoperfusion with R-004 Amberlite resin for treating acute poisoning.. BMJ. 2(6100). 1453–1456. 47 indexed citations
11.
Sharpstone, P. (1977). Diseases of the urinary system. Prescribing for patients with renal failure.. BMJ. 2(6078). 36–37. 3 indexed citations
12.
Cameron, J. S., David R. Turner, C S Ogg, P Sharpstone, & Colin B. Brown. (1974). The Nephrotic Syndrome in Adults with ‘Minimal Change’ Glomerular Lesions. QJM. 43(171). 461–88. 84 indexed citations
13.
Sharpstone, P, M O Rake, Κ.B. Shilkin, et al.. (1972). The Diagnosis of Primary Malignant Tumours of the Liver<subtitle>FINDINGS IN 48 CONSECUTIVE PATIENTS</subtitle>. QJM. 41(161). 99–110. 7 indexed citations
14.
Sharpstone, P, et al.. (1971). Halothane Hepatitis—A Preventable Disease?. BMJ. 1(5746). 448–450. 23 indexed citations
15.
Fleischer, M., P Sharpstone, S. B. Osborn, & Rachel Williams. (1971). Liver scintiscanning in acute hepatic necrosis.. PubMed. 44(521). 401–2. 5 indexed citations
16.
Parkes, J. D., P Sharpstone, & Roger Williams. (1970). LEVODOPA IN HEPATIC COMA. The Lancet. 296(7687). 1341–1343. 70 indexed citations
17.
Sharpstone, P, C S Ogg, & J S Cameron. (1969). Nephrotic Syndrome Due to Primary Renal Disease in Adults: I. Survey of Incidence in South-east England. BMJ. 2(5656). 533–535. 42 indexed citations
18.
Sharpstone, P, C S Ogg, & J S Cameron. (1969). Nephrotic Syndrome Due to Primary Renal Disease in Adults: II. A Controlled Trial of Prednisolone and Azathioprine. BMJ. 2(5656). 535–539. 55 indexed citations
19.
Sharpstone, P, et al.. (1967). Parenteral nutrition in renal failure. Postgraduate Medical Journal. 43(496). 81–91. 21 indexed citations
20.
Anderson, Ryan J., et al.. (1964). Enlargement of Parotid Gland Due to Sarcoidosis. BMJ. 2(5413). 861–862. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026